Skip to main content
. Author manuscript; available in PMC: 2010 Jul 26.
Published in final edited form as: Pharmacogenet Genomics. 2008 Jan;18(1):67–75. doi: 10.1097/FPC.0b013e3282f3606e

Table 2.

CYP2A6*23 genotype groups and their mean adjusted 3HC/COT ratio

Allele Genotype n Mean adjusted 3HC/COT SD % of wildtype p-valuesa
*23 *1/*1 150 1.210 0.634 100 0.04
*1/*23 4 0.756 0.540 62.4
*23/*23 1 0 0 0
*17 *1/*1 150 1.210 0.634 100 <0.001
*1/*17 19 0.672 0.468 55.5
*17/*17 3 0.109 0.095 9.1
More than one variant *1/*1 150 1.210 0.634 100 0.02
*17/*23 2 0.259 0.366 21.4
*20/*23 2 0.555 0.512 45.8
*9/*23 1 1.032 0 85.2
a

The adjusted 3HC/COT ratio was compared between wildtype individuals (CYP2A6*1/*1) to other genotype groups combined using a two-tailed independent t-test.